NUCLIK Trademark

Trademark Overview

On Friday, October 30, 2015, a trademark application was filed for NUCLIK with the United States Patent and Trademark Office. The USPTO has given the NUCLIK trademark a serial number of 86805089. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 14, 2020. This trademark is owned by GlaxoSmithKline Intellectual Property Limited. The NUCLIK trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances in the nature of prefilled auto-injectors containing pharmaceutical preparations for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances in the nature of prefilled auto-injectors containing pharmaceutical preparations and substances for the treatment of pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances in the nature of prefilled auto-injectors containing pharmaceutical preparations and substances for the treatment of metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, and psychiatric related diseases and disorders; Vaccines
nuclik

General Information

Serial Number86805089
Word MarkNUCLIK
Filing DateFriday, October 30, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 14, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 12, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances in the nature of prefilled auto-injectors containing pharmaceutical preparations for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances in the nature of prefilled auto-injectors containing pharmaceutical preparations and substances for the treatment of pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances in the nature of prefilled auto-injectors containing pharmaceutical preparations and substances for the treatment of metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, and psychiatric related diseases and disorders; Vaccines
Pseudo MarkNEW CLICK

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 4, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxoSmithKline Intellectual Property Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
Party NameGlaxoSmithKline Intellectual Property Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Monday, December 14, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 14, 2020ABANDONMENT - NO USE STATEMENT FILED
Tuesday, February 25, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 24, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, February 24, 2020EXTENSION 5 GRANTED
Monday, February 17, 2020EXTENSION 5 FILED
Monday, February 24, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, February 17, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, February 17, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, February 17, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, February 17, 2020TEAS EXTENSION RECEIVED
Thursday, November 7, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 5, 2019EXTENSION 4 GRANTED
Tuesday, November 5, 2019EXTENSION 4 FILED
Tuesday, November 5, 2019TEAS EXTENSION RECEIVED
Friday, November 1, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, November 1, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 2, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 30, 2019EXTENSION 3 GRANTED
Tuesday, April 30, 2019EXTENSION 3 FILED
Tuesday, April 30, 2019TEAS EXTENSION RECEIVED
Wednesday, October 31, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 29, 2018EXTENSION 2 GRANTED
Monday, October 29, 2018EXTENSION 2 FILED
Monday, October 29, 2018TEAS EXTENSION RECEIVED
Wednesday, May 9, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 7, 2018EXTENSION 1 GRANTED
Monday, May 7, 2018EXTENSION 1 FILED
Monday, May 7, 2018TEAS EXTENSION RECEIVED
Tuesday, November 7, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 26, 2017TTAB RELEASE CASE TO TRADEMARKS
Tuesday, September 26, 2017OPPOSITION TERMINATED NO. 999999
Tuesday, September 26, 2017OPPOSITION DISMISSED NO. 999999
Wednesday, August 10, 2016OPPOSITION INSTITUTED NO. 999999
Wednesday, May 11, 2016EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, April 12, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 12, 2016PUBLISHED FOR OPPOSITION
Wednesday, March 23, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, February 29, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 22, 2016ASSIGNED TO EXAMINER
Thursday, November 5, 2015NOTICE OF PSEUDO MARK E-MAILED
Wednesday, November 4, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, November 3, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

nuclik preparations pharmaceutical substances treatment injectors containing nature auto prefilled disorders